TAYLOR BETH A. (VP Finance & Chief Acctg Offcr) sold 11.1% of their position (7.02K shares) of ENDOCYTE INC on the open market
Open‑market sale worth $109.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/9/2018ACC: 0001179110-18-012090
Officer· VP Finance & Chief Acctg Offcr
Since Aug 2018
-7.02K
Net shares
Net seller
$109.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.02K
Price / share
$15.56
Trade value
$109.29K
% of position
11.1%
10/5/2018
63.36K→56.34K
Total
Net shares
−7.02K
Net value
-$109.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/5/2018 | S · Sale | −7.02K | $15.56 | $109.29K | 11.1% | 63.36K | 56.34K |
| Total | −7.02K | -$109.29K | ||||||
Derivative Transactions0
No derivative transactions reported